Mereo BioPharma Group plc American Depositary Shares
$0.31
$0.02 (+6.17%)
$0.28Day Range$0.31
Key Statistics
Market Cap
$46.33M
Shares Outstanding
159.7M
Primary Exchange
XNAS
Currency
USD
Type
ADRC
IPO Date
Apr 24, 2018
Round Lot
100
Locale
US
Trading Data
Day Open
$0.28
Day High
$0.31
Day Low
$0.28
Volume
1.34M
VWAP
$0.30
Prev Close
$0.29
Transactions
--
Acc. Volume
--
About Mereo BioPharma Group plc American Depositary Shares
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
PHARMACEUTICAL PREPARATIONSSIC 283439 employeesONE CAVENDISH PLACE, LONDON, W1G 0QF4403330237300IPO Apr 24, 2018US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001719714
- Composite FIGI
- BBG00KFWZC67
- Share Class FIGI
- BBG00KFWZCX7
- Ticker Root
- MREO
- SIC Code
- 2834
About Mereo BioPharma Group plc American Depositary Shares (MREO) Stock
Mereo BioPharma Group plc American Depositary Shares (MREO) closed the 2026-09-18 session at $0.31, up 6.17% versus the previous close (+0.02). The stock opened at $0.28 and traded between $0.28 and $0.31 during that session. Session trading volume was 1.3M shares. The volume-weighted average price (VWAP) is $0.30.
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
Mereo BioPharma Group plc American Depositary Shares has a market capitalization of $46.3 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. MREO is listed on the XNAS exchange. The company employs approximately 39 people. The recorded listing date is 2018-04-24.
On this page you can find market MREO stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.